Healio: PET may be beneficial to guide revascularization strategy for CAD

September 26, 2020

PET perfusion and flow assessment may guide revascularization strategies for patients with carotid artery disease (CAD).

Dr. Timothy Bateman, co-director of cardiovascular radiologic imaging at Saint Luke's Mid America Heart Institute, gave a presentation on the topic at the Scientific Session and Exhibition of the American Society of Nuclear Cardiology.

“PET offers a lot of information that we historically have not been able to get from a spatially relative perfusion defect analysis typically provided by a SPECT study,” Dr. Batement said.

Read the full Healio article: PET may be beneficial to guide revascularization strategy for CAD

Related Content

ISCHEMIA
TCTMD: ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up
The ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial focused on evaluating survival and benefits to the patients quality of life.
Healio: DARE-19: Dapagliflozin could target key mechanisms activated in COVID-19
As the entire world comes together to attempt to find a vaccine and treatments for this global pandemic, it is exciting that an international trial of this nature was created and is being led by doctors and researchers here in
KMBC: Worldwide clinical drug trial for COVID-19 led by a doctor at Saint Luke's
KMBC: Worldwide clinical drug trial for COVID-19 led by a doctor at Saint Luke's
As the entire world comes together to attempt to find a vaccine and treatments for this global pandemic, it is exciting that an international trial of this nature was created and is being led by doctors and researchers here in Kansas City.